InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
+3.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by HASTINGS DAVID C, Director. Director active across 3 companies, notably Entasis Therapeutics Holdings Inc.. Cumulatively, 11 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €71k. History available since 18 January 2022. The latest transaction was disclosed on 14 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
2,875 sharesCommon StockSEC:0001237401-26-000002:0
90,100 shares0Common SharesSEC:0001447028-25-000050:0
22,183 shares@ US$3.283100.0% of flowCommon SharesSEC:0001447028-25-000040:0
23,000 shares0Common StockSEC:0000950170-24-076239:0
112,500 shares0Common SharesSEC:0001447028-24-000027:0
10,000 shares0Common StockSEC:0000950170-23-029609:0
79,000 shares0Common SharesSEC:0001447028-23-000009:0
22,000 shares@ US$2.20100.0% of flowCommon StockSEC:0001104659-22-078789:0
10,000 shares0Common StockSEC:0001209191-22-038666:0
27,500 shares0Common StockSEC:0001104659-22-005412:0
27,500 shares0Common StockSEC:0001104659-22-005412
11 of 11 declarations
About HASTINGS DAVID C
David C. Hastings is a Director at Entasis Therapeutics Holdings Inc. and SCYNEXIS INC. In this role, he participates in the strategic decisions of these companies and ensures good governance. His experience in the biopharmaceutical sector allows him to provide valuable insights during board discussions.
